Levetiracetam for benign epilepsy of childhood with centrotemporal spikes-three cases.

Seizure

Department of Paediatric Neurology, University of California San Francisco, 2340 Clay Street, Third Floor, San Francisco, CA 94115, USA.

Published: April 2003

Benign epilepsy with centrotemporal spikes (BECTS), also known as benign rolandic epilepsy (BRE) of childhood represents 15% of all childhood epilepsies [Handbook of Epilepsy Treatment (2000)]. A majority of these patients do no require treatment; however, in those cases where treatment is justified, the most efficacious medication with a benign safety profile should be selected. We present three clinical cases of otherwise healthy children with BECTS who were treated only with levetiracetam. All three of these children remain seizure-free and are experiencing no reported side effects.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1059-1311(03)00004-9DOI Listing

Publication Analysis

Top Keywords

benign epilepsy
8
levetiracetam benign
4
epilepsy
4
epilepsy childhood
4
childhood centrotemporal
4
centrotemporal spikes-three
4
spikes-three cases
4
cases benign
4
epilepsy centrotemporal
4
centrotemporal spikes
4

Similar Publications

Research progress on pathogenesis and treatment of febrile seizures.

Life Sci

December 2024

Research Institute of Chinese Medical Clinical Foundation and Immunology, College of Basic Medical Science & Wenzhou TCM Hospital of Zhejiang Chinese Medical University, Zhejiang Chinese Medical University, Zhejiang, China. Electronic address:

Febrile seizures (FSs) are the most common pediatric neurological disorder, affecting approximately 5 % of children aged 6 months to 5 years. While most FSs are self-limiting and benign, about 20-30 % present as complex FSs (CFSs), which pose a risk of acute brain injury and the development of temporal lobe epilepsy. Various factors, including age, geographical distribution, and type of infection influence the occurrence of FS.

View Article and Find Full Text PDF

Background: Rosai-Dorfman disease (RDD), or sinus histiocytosis with massive lymphadenopathy (SHML), is a rare benign disorder characterized by the proliferation of histiocytes of uncertain origin. Central nervous system (CNS) involvement, particularly intraventricular, is exceptionally rare and poses significant diagnostic challenges due to its non-specific clinical and radiographic presentation. This study aims to present a case of intraventricular RDD and review existing literature on its clinical features, treatment strategies, and prognosis.

View Article and Find Full Text PDF

Clinical, etiological, and therapeutic profile of early-onset absence seizures: A case series analysis.

Clin Neurol Neurosurg

December 2024

Pediatric Unit, Department of Medical and Surgical Sciences of Mothers, Children and Adults, University of Modena and Reggio Emilia, Modena 41121, Italy. Electronic address:

Typical absence seizures represent a distinctive form of epileptic activity typically observed in pediatric populations, predominantly manifesting between the ages of 4 and 10, constituting Childhood Absence Epilepsy (CAE). However, a subset of patients presents with Early-onset Absence Epilepsy (EOAE), characterized by seizure onset before the fourth year of life, often displaying favorable outcomes with antiseizure medication. Conversely, atypical absence seizures exhibit prolonged duration and frequently entail tonic, atonic, or myoclonic motor elements, suggesting a more severe clinical course, commonly associated with epileptic encephalopathies of childhood onset.

View Article and Find Full Text PDF

Four neurologic diseases affect dogs of the Lagotto Romagnolo (LR) breed, namely benign familial juvenile epilepsy (BFJE), vacuolar storage disease, and 2 forms of cerebellar cortical degeneration. Intraneuronal inclusion bodies in cerebellar Purkinje cells were first described in the BFJE phenotype. Upon further characterization of these diseases, similar inclusions were also noted in the brain of LRs used as controls.

View Article and Find Full Text PDF
Article Synopsis
  • * A recent study successfully treated three young TSC patients with intracranial aneurysms using the Pipeline embolization device (PED), achieving complete aneurysm closure without complications.
  • * The findings suggest that the PED offers a safe endovascular option that may help avoid additional surgeries for TSC-related issues, but more research is needed to confirm its long-term effectiveness in children.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!